MiMedx Group (NASDAQ:MDXG) Price Target Raised to $8.00 at Craig HallumMarket Beat·1 day ago, 02:00 PMMDXG-0.11%
MiMedx Group's (MDXG) "Overweight" Rating Reaffirmed at Cantor FitzgeraldMarket Beat·Aug 17 at 07:06 AMMDXG-0.11%
SMTI: Q2 2026 revenue grew 9% to $28.1M, with a 93% gross margin and a pending merger with MiMedxQuartr·Aug 11 at 04:12 PMSMTI-0.06%MDXG-0.11%
Sanara MedTech koreksi biaya terminasi merger; ubah jadi USD 9,66 juta dari USD 22,54 jutaPUBT·Aug 11 at 03:06 PMSMTI-0.06%MDXG-0.11%
13:16 ET$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Sanara MedTech Inc. (NASDAQ: SMTI)prnewswire·Jul 30 at 12:16 PMSMTI-0.06%MDXG-0.11%
03:59 ETShareholder Alert: Ademi LLP investigates whether Sanara MedTech Inc. is obtaining a Fair Price for Public Shareholdersprnewswire·Jul 30 at 03:00 AMSMTI-0.06%MDXG-0.11%
MiMedx to buy Sanara MedTech in cash-and-stock deal valued at USD 35 a sharePUBT·Jul 29 at 03:02 PMSMTI-0.06%MDXG-0.11%
MiMedx Q2 FY26 net loss widens to $14.84 million; net sales drop 34.7% to $64.36 millionPUBT·Jul 29 at 03:27 PMMDXG-0.11%
